Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 453, Suchdauer: 6.17s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial

von Griffin, Paul ; Morrissey, Orla ; Yong, Michelle ; et al.

In The Lancet Infectious Diseases July 2025 25(7):813-826
- View full text via DOI
Merkliste

2
Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study

von Jones, Scott ; Hicks, Bethany ; Callaby, Helen ; et al.

In The Lancet Microbe April 2025 6(4)
- View full text via DOI
Merkliste

3
ATRX mutations mediate an immunogenic phenotype and macrophage infiltration in neuroblastoma

von Lorenzi, Federica ; Jostes, Sina ; Gao, Qiong ; et al.

In Cancer Letters 31 March 2025 613
- View full text via DOI
Merkliste

4
Yellow fever in South America – A plea for action and call for prevention also in travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN

von Alfonso J. Rodriguez-Morales ; Abdulaziz H. Alhazmi ; Abraham Katime ; et al.

Travel Medicine and Infectious Disease, Vol 67, Iss , Pp 102871- (2025)

Schlagworte: Yellow fever; South America; Travelers' health; Vaccination; Surveillance; Vector-borne diseases; Arctic medicine. Tropical medicine; RC955-962; Infectious and parasitic diseases; RC109-216
- View full text via DOI
Merkliste

5
Evaluation of a multiplexed immunoassay for assessing long-term humoral immunity Orthopoxviruses

von Hicks, Bethany ; Jones, Scott ; Callaby, Helen ; et al.

In Vaccine 2 December 2024 42(26)
- View full text via DOI
Merkliste

6
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trialResearch in context

von O. Abani ; A. Abbas ; F. Abbas ; et al.

EClinicalMedicine, Vol 81, Iss , Pp 103080- (2025)

Schlagworte: COVID-19; Corticosteroid; Dexamethasone; Mortality; Clinical trial; Medicine (General); R5-920
- View full text via DOI
Merkliste

7
Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland

von Wildman, Eden ; Rampling, Tommy ; Morris, Sheila ; et al.

In The Lancet Microbe November 2023 4(11):e863-e874
- View full text via DOI
Merkliste

8
Paediatric acute hepatitis of unknown aetiology: a national investigation and adenoviraemia case-control study in the UK

von Mandal, Sema ; Simmons, Ruth ; Ireland, Georgina ; et al.

In The Lancet Child & Adolescent Health November 2023 7(11):786-796
- View full text via DOI
Merkliste

9
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

von Liu, Xinxue ; Munro, Alasdair P S ; Wright, Annie ; et al.

In Journal of Infection July 2023 87(1):18-26
- View full text via DOI
Merkliste

10
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study

von Dunning, Jake ; Fink, Douglas L ; Milligan, Iain D ; et al.

In The Lancet Infectious Diseases May 2023 23(5):589-597
- View full text via DOI
Merkliste

11
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2

von Szubert, Alex J. ; Pollock, Katrina M. ; Cheeseman, Hannah M. ; et al.

In eClinicalMedicine February 2023 56
- View full text via DOI
Merkliste

12
Targetable NOTCH1 rearrangements in reninoma

von Taryn D. Treger ; John E. G. Lawrence ; Nathaniel D. Anderson ; et al.

Nature Communications, Vol 14, Iss 1, Pp 1-10 (2023)

Schlagworte: Science
- View full text via DOI
Merkliste

13
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial

von Munro, Alasdair P.S. ; Bartholomew, Jazz ; Presland, Laura ; et al.

In The Lancet Respiratory Medicine November 2022 10(11):1049-1060
- View full text via DOI
Merkliste

14
Clinical features and management of human monkeypox: a retrospective observational study in the UK

von Abouyannis, Mike ; Al-Balushi, Asma ; Aston, Stephen ; et al.

In The Lancet Infectious Diseases August 2022 22(8):1153-1162
- View full text via DOI
Merkliste

15
Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection

von Stafford, Adam ; Rimmer, Stephanie ; Gilchrist, Mark ; et al.

In The Lancet Infectious Diseases June 2023 23(6):e218-e226
- View full text via DOI
Merkliste

16
Monkeypox virus isolation from longitudinal samples from four patients to infer risk of onwards transmission: an interim analysis

von Callaby, H. ; Emery, K. ; Killip, M. ; et al.

In Journal of Hospital Infection May 2023 135:139-144
- View full text via DOI
Merkliste

17
Imported rickettsial infections to the United Kingdom, 2015–2020

von Warrell, Clare E. ; Osborne, Jane ; Nabarro, Laura ; et al.

In Journal of Infection May 2023 86(5):446-452
- View full text via DOI
Merkliste

18
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

von Adams, Kirsty ; Amini, Fahimah ; Atako, Nafisah B ; et al.

In eClinicalMedicine February 2022 44
- View full text via DOI
Merkliste

19
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals

von Ashley D. Otter ; Scott Jones ; Bethany Hicks ; et al.

Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)

Schlagworte: Science
- View full text via DOI
Merkliste

20
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study

von Frampton, Dan ; Rampling, Tommy ; Cross, Aidan ; et al.

In The Lancet Infectious Diseases September 2021 21(9):1246-1256
- View full text via DOI
Merkliste

21
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

von Munro, Alasdair P S ; Feng, Shuo ; Janani, Leila ; et al.

In The Lancet Infectious Diseases August 2022 22(8):1131-1141
- View full text via DOI
Merkliste

22
Operationalisation and findings of a First Few X (FFX) investigation of early mpox clade Ib cases and their close contacts in the United Kingdom

von Shah, Anita A. ; Inzoungou-Massanga, Carmellie ; Awokoya, Motolani ; et al.

In Public Health July 2026 256
- View full text via DOI
Merkliste

23
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

von Aban, Marites ; Abeyskera, Kushala W.M. ; Aboagye, Jeremy ; et al.

In The Lancet 6-12 March 2021 397(10277):881-891
- View full text via DOI
Merkliste

24
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

von Aban, Marites ; Abayomi, Fatola ; Abeyskera, Kushala ; et al.

In The Lancet 9-15 January 2021 397(10269):99-111
- View full text via DOI
Merkliste

25
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.

von Liu, Xinxue ; Munro, Alasdair P S ; Feng, Shuo ; et al.

In Journal of Infection June 2022 84(6):795-813
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag